REFERENCES
- Foley RN, Parfey RS. Cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(Suppl. 3)112–119
- Krane V, Wanner C. Cardiovascular disease and predisposing factors in chronic renal failure. J Clin Basic Cardiol. 2001; 4: 97–100
- Jaradat MI, Molitoris BA. Cardiovascular disease in patients with chronic kidney disease. Seminars in Nephrol. 2002; 22: 459–473
- Levin A. Prevalence of cardiovascular damage in early renal disease. Nephrol Dial Transplant. 2001; 16(Suppl. 2)7–11
- Kunz K, Dimitrov Y, Muller S, Chantrel F, Hannedouche T. Uremic cardiomyopathy. Nephrol Dial Transplant. 1998; 13(Suppl. 4)39–43
- Foley RN, Parfey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186–192
- Drüeke TB. Aspects of cardiovascular burden in pre-dialysis patients. Nephron. 2000; 85(Suppl. 1)9–14
- Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358–367
- Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450–458
- Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995; 25: 879–884
- Kutlay S, Dincer I, Sengül S, Nergizoglu G, Duman N, Ertürk S. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis. 2006; 47: 485–492
- Covic A, Goldsmith D. Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uraemic patients. Nephrol Dial Transplant. 2002; 17: 1737–1741
- Csiky B, Kovacs T, Wagner L, Vass T, Nagy J. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy. Nephrol Dial Transplant. 1999; 14: 86–90
- Ertürk S, Ertug AE, Ates K, et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in hemodialysis patients. Nephrol Dial Transplant. 1996; 11: 2050–2054
- Farmer CK, Goldsmith DJ, Quin JD, et al. Progression of diabetic nephropathy-is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrol Dial Transplant. 1998; 13: 635–639
- Farmer CKT, Goldsmith DJA, Cox P, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uremia, renal replacement therapy, and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997; 12: 2301–2307
- Yasunari K, Maeda K, Watanabe T, Nakamura M, Yoshikawa J, Asada A. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. J Am Coll Cardiol. 2004; 43: 2116–2123
- Ertürk S, Nergizoglu G, Ates K, et al. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in hemodialysis patients. Nephrol Dial Transplant. 1999; 14: 1912–1916
- Ridker PM, Cushman M, Stampfer MJ, Russel PT, Hennekens CH. Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973–976
- Stenvinkel P, Heimburger O, Paultre F, et al. Strong associations between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55: 1899–1911
- Park CW, Shin YS, Kim CM, et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis. 2002; 40: 1230–1239
- Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney Int. 2001; 59: 407–414